Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

<p>CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday. This prestigious award highlights Mr. McEnany’s outstanding […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/patrick-j-mcenany-chairman-and-ceo-of-catalyst-pharmaceuticals-receives-prestigious-2023-lifetime-achievement-award-from-bioflorida/">Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>